Appeal over $6 million penalty for Nurofen rejected


A failed high court appeal means the company that manufactures Nurofen must pay a $6 million penalty it was handed for misleading consumers with its pain relief range. The penalty, revised up from an initial $1.7 million, is the highest ever issued for misleading conduct under Australian Consumer Law. The ACCC accused manufacturer Reckitt Benckiser ...


Already a member? Login to keep reading


OR
© 2017 the limbic